Literature DB >> 14690101

A prospective, randomized, double-blind comparison of epidural levobupivacaine 0.5% with epidural ropivacaine 0.75% for lower limb procedures.

V A Peduto1, S Baroncini, S Montanini, R Proietti, L Rosignoli, R Tufano, A Casati.   

Abstract

BACKGROUND AND
OBJECTIVE: This prospective, randomized, observer-blinded study compared onset time and duration of epidural anaesthesia produced by with levobupivacaine and ropivacaine for lower limb surgery.
METHODS: ASA I-III adult patients undergoing elective lower limb procedures were randomized to receive epidural levobupivacaine 0.5% 15 mL (n = 30) or epidural ropivacaine 0.75% 15 mL (n = 35). A blinded observer evaluated onset time and regression of motor and sensory block, and intraoperative needs for fentanyl supplementation (0.1 mg intravenously).
RESULTS: With levobupivacaine, onset time was 29 +/- 24 min, with ropivacaine it was 25 +/- 22 min (P = 0.41). Complete resolution of motor block required 105 +/- 63 min with levobupivacaine and 95 +/- 48 min with ropivacaine (P = 0.86). The time for regression of sensory block to T12 was 185 +/- 77 min with levobupivacaine and 201 +/- 75 min with ropivacaine (P = 0.46). Analgesic supplementation was required in one patient receiving levobupivacaine (3.5%) and in two patients receiving ropivacaine (5.7%) (P = 0.99).
CONCLUSIONS: In adults undergoing lower limb surgery, levobupivacaine 0.5% 15 mL produces an epidural block with the same clinical profile as ropivacaine 0.75% 15 mL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690101     DOI: 10.1017/s0265021503001583

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  12 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 3.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

4.  Evaluation of the effects of ketamine on spinal anesthesia with levobupivacaine or ropivacaine.

Authors:  Yan Zhang; Hong Lin; Wen-Bo Yi
Journal:  Exp Ther Med       Date:  2016-08-10       Impact factor: 2.447

5.  The effects of Different Concentrations and Equivalent Volumes of Levobupivacaine in Epidural Anesthesia.

Authors:  Dilek B Surav; Ayse Hanci; G Ulufer Sivrikaya; Metin Bektas; Leyla T Kilinc
Journal:  Curr Ther Res Clin Exp       Date:  2011-04

Review 6.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

7.  Ropivacaine: A review of its pharmacology and clinical use.

Authors:  Gaurav Kuthiala; Geeta Chaudhary
Journal:  Indian J Anaesth       Date:  2011-03

8.  Hemiarthroplasty in high risk elderly patient under epidural anesthesia with 0.75% ropivacaine-fentanyl versus 0.5% bupivacaine-fentanyl: Clinical trial.

Authors:  Bhawna Rastogi; Kumkum Gupta; Avinash Rastogi; Prashant K Gupta; Apoorva B Singhal; Ivesh Singh
Journal:  Saudi J Anaesth       Date:  2013-04

9.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Clinical profile of levobupivacaine in regional anesthesia: A systematic review.

Authors:  Sukhminder Jit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.